Atlassian Jira and Confluence Enterprise Renewal ( Brand Name restriction )

2026-11-03

Acquisition Description : This notice is a combined synopsis / solicitation for commercial items using Simplified Acquisition Procedures . This acquisition will be made in accordance with the format in Federal Acquisition Regulation ( FAR ) Subpart 12 . 6 “ Streamlined Procedures for Evaluation and solicitation for commercial Items ,” as applicable , and as supplemented with additional information included in this notice . This announcement constitutes the only solicitation ( a written solicitation will not be issued ) and quotes are being requested . This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures ( SAP ). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular ( FAC ) 2024 - 04 . The Solicitation number is RFQ - CC - 26 - 000701 and the solicitation is issued as a Request for Quotes ( RFQ ). _________________________________________________________________________________________________________The National Institutes of Health ( NIH ) Clinical Center ( CC ), Department of Clinical Research Informatics ( DCRI ), utilizes Atlassian Jira Software and Confluence as core platforms for IT Governance , Quality Management , and critical system documentation . The continuity of these platforms is essential for regulatory compliance and system stability . A renewal of this software is required . Justification : The Jira workflows supporting Master Control and clinical manufacturing have been rigorously developed , configured , tested , and validated to meet stringent FDA audit and compliance standards . Migrating this workflow to a different platform would require a complete re - validation of the new system , including drafting new System Security Plans ( SSPs ), developing new audit trails , training all affected staff ( including Quality Assurance and Clinical Manufacturing personnel ), and re - integrating with Master Control . The estimated cost and time associated with this re - validation and regulatory approval process would result in substantial duplication of cost and unacceptable delays to ongoing , life - saving clinical research protocols . Requirements : ATL - MP - JMWE4JIRA - 100R : Jira Workflow Toolbox Data Center for Jira Software ( Data Center ) 100 UsersATL - JSWDC - 100R : Jira Software ( Data Center ) 100 UsersATL - MP - SCRIPTRUNNER4JDC - 100R : Jira Data Center for Jira Software -( Data Center ) 100 UsersATL - CDC - 250R : Confluence ( Data Center ) 250 UsersATL - MP - MSSGFIELD4JDC - 100R : Message field Data Center for Jira Software ( Data Center ) 100 UsersPlace of Performance or Delivery : The estimated Period of Performance is ( an extension has been secured with the manufacturer ): Start Date : 12 / 31 / 2025End Date : 12 / 30 / 2026Place of Performance : NIH Clinical Center in Bethesda , MDOfferors must be offical authorized resellers authorized by the creator / manufacturer of the software . _________________________________________________________________________________________________________The following FAR provisions apply to this acquisition : FAR 52 . 212 - 1 Instructions to Offerors Commercial Items ( SEPT 2023 ) FAR 52 . 212 - 3 Offerors Representations and Certifications - Commercial Items ( DEC 2022 ) FAR 52 . 204 - 7 System for Award Management ( OCT 2018 )( Offerors must complete annual representations and certifications on - line at http :// www . sam . gov / in accordance with FAR 52 . 212 - 3 Offerors Representations and Certifications - Commercial Items ( Please ensure 52 . 209 - 2 -- Prohibition on Contracting with Inverted Domestic Corporations -- Representation . ( Nov 2015 ) is updated in your SAM record ) FAR 52 . 203 - 18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation ( JAN 2017 ) 52 . 204 – 26 Covered Telecommunications Equipment or Services - Representation ( OCT 2020 ) *** Must complete representation if attached to this solicitation - see attachment 52 . 204 - 26The following FAR contract clauses apply to this acquisition : FAR 52 - 212 - 4 Contract Terms and Conditions Commercial Items ( DEC 2022 ) FAR 52 - 212 . 5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items ( SEP 2023 ) FAR 52 . 232 - 40 Providing Accelerated Payments to Small Business Subcontractors ( MAR 2023 ) FAR 52 . 204 - 13 System for Award Management Maintenance ( Oct 2018 ) FAR 52 . 204 - 25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment ( NOV 2021 ) HHSAR 352 . 222 - 70 , Contractor Cooperation in Equal Employment Opportunity Investigations ( December 2015 ) 52 . 252 - 2 -- Clauses Incorporated by Reference . ( Feb 1998 ) This contract incorporates one or more clauses by reference , with the same force and effect as if they were given in full text . Upon request , the Contracting Officer will make their full text available . Also , the full text of a clause may be accessed electronically at this address : http :// farsite . hill . af . mil / vffara . htm . By submission of an offer , the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management ( SAM ) database prior to award , during performance , and through final payment of any contract , basic agreement , basic ordering agreement , or blanket purchasing agreement resulting from this solicitation ( www . sam . gov ). Copies of the above - referenced provisions and clauses are available from http :// www . acquisition . gov / far / loadmainre . html & http : // www . hhs . gov / regulation / index . html or , upon request , either by telephone or fax . The government intends to award a “ firm fixed price ” order ( in the form of a PO , IDIQ , or BPA ) to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein . The government will evaluate quotes to determine the proposal that conforms to the solicitation and presents the best value to the government ( eg . the most advantageous to the Government based on price , performance , availability of funds , etc .). The award will be made based on technical capability to meet the requirements / technical factors , price , and past performance . _________________________________________________________________________________________________________Submission shall be received not later than 01 / 14 / 2026 by @ 04 : 00 PM EST . Offers may be emailed to Lu Chang at < lu - chang . lu @ nih . gov > by the date and time stated above . Late submission shall be treated in accordance with the solicitation provision at FAR 52 . 212 - 1 ( f ). All responsible sources may submit an offer that will be considered by this Agency . Any questions or concerns regarding this solicitation should be forwarded in writing via email to the respective contacts above . Offers shall include RFQ number in the subject line ( RFQ - CC - 26 - 000701 ). Offers shall also include the price , delivery timeframes , and any other required documentation / information as mentioned above . Offers that do not meet these requirements may be excluded from consideration .

Maryland

2026-05-02